We also found that the methylation levels of these genes in the high-risk patients were higher than those in the low-risk patients, suggesting that ZNF154, TSPYL5, and CDKL2 may play an antitumor role in the development and progression of HCC. This evidence concerns the gene TSPYL5 and hepatocellular carcinoma.